Showing results (731-740 of 3,318) with videos related to
Sort By:
Pageof 332
Journal of Clinical Psychopharmacology|December 1, 1986
The 2-mg dexamethasone suppression test in differentiating major depression with psychosis from schizophreniaC G ClowerJournal of Clinical Psychopharmacology|October 8, 1997
The effects of phenytoin on impulsive and premeditated aggression: a controlled studyE S Barratt, M S Stanford, A R Felthous, et al.Journal of Clinical Psychopharmacology|October 8, 1997
Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypothesesH S Gill, C L DeVane, S C RischJournal of Clinical Psychopharmacology|October 8, 1997
Two rapid-dose titrations of sertindole in patients with schizophreniaJ J Sramek, R J Mack, W Awni, et al.Journal of Clinical Psychopharmacology|December 31, 1997
How long should pindolol be associated with paroxetine to improve the antidepressant response?R Zanardi, F Artigas, L Franchini, et al.Journal of Clinical Psychopharmacology|June 9, 1998
Enhanced selective attention after low-dose administration of the benzodiazepine antagonist flumazenilR Smolnik, R Pietrowsky, H L Fehm, et al.Journal of Clinical Psychopharmacology|April 29, 1998
Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effectsC R Rush, D L Armstrong, J A Ali, et al.Journal of Clinical Psychopharmacology|April 29, 1998
Serum levels of valproate and carbamazepine in breastfeeding mother-infant pairsK L Wisner, J M PerelJournal of Clinical Psychopharmacology|April 29, 1998
The development of treatment resistance in patients with schizophrenia: a clinical and pathophysiologic perspectiveJ A Lieberman, B Sheitman, M Chakos, et al.Journal of Clinical Psychopharmacology|March 28, 2023
Long-Term Outcome of Clozapine in Treatment-Resistant SchizophreniaMyung A Lee, Philip Cola, Karu Jayathilake, et al.Pageof 332